SASS6 促进肺腺癌肿瘤增殖，并与 TP53 和免疫浸润相关。

SASS6 promotes tumor proliferation and is associated with TP53 and immune infiltration in lung adenocarcinoma.

机构信息

Department of Thoracic Surgery, Liuzhou People's Hospital affiliated to Guangxi Medical University, Liuzhou, Guangxi, China.

Department of Nephrology, Liuzhou People's Hospital affiliated to Guangxi Medical University, Liuzhou, Guangxi, China.

出版信息

Clin Exp Med. 2024 Oct 24;24(1):243. doi: 10.1007/s10238-024-01510-0.

DOI:10.1007/s10238-024-01510-0

PMID:39443355

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11499408/

Abstract

The most common type of non-small cell lung cancer is lung adenocarcinoma (LUAD), which is characterized by high morbidity and poor survival. Up-regulation of SASS6 expression can lead to the progression of various malignant tumors. However, there are no relevant studies on the role of SASS6 in LUAD. SASS6 was highly expressed in most tumors, reflecting a good diagnostic value, and its overexpression in LUAD indicated discouraging overall prognosis. Functional enrichment analysis suggested that SASS6 was associated with cell cycle in LUAD. In addition, patients with high SASS6 expression had worse immune infiltration, but higher TMB and immune checkpoint, and higher sensitivity to multiple targeted drugs such as osimertinib. Cell experiments confirmed that knockdown of SASS6 could inhibit the viability of tumor cells.SASS6 has important value in the diagnosis of cancer. In particular, SASS6 is a crucial factor in the progression of LUAD, and has important clinical value, especially in the diagnosis, prognosis and treatment.

摘要

最常见的非小细胞肺癌类型是肺腺癌（LUAD），其发病率高，生存状况差。SASS6 表达上调可导致多种恶性肿瘤的进展。然而，目前尚无关于 SASS6 在 LUAD 中作用的相关研究。SASS6 在大多数肿瘤中高表达，反映了良好的诊断价值，其在 LUAD 中的过表达预示着整体预后不佳。功能富集分析表明，SASS6 与 LUAD 中的细胞周期有关。此外，SASS6 高表达的患者免疫浸润更差，但 TMB 和免疫检查点更高，对奥希替尼等多种靶向药物更敏感。细胞实验证实，敲低 SASS6 可抑制肿瘤细胞的活力。SASS6 在癌症诊断中具有重要价值。特别是，SASS6 是 LUAD 进展的关键因素，具有重要的临床价值，特别是在诊断、预后和治疗方面。